We found that PMEPA1 protein levels were increased in high grade gliomas (WHO III–IV; n = 40) relative to normal brain tissues (n = 6) and low grade gliomas (WHO II; n = 20; Fig. 1a, b). The gene discussed is PMEPA1; the disease is central nervous system cancer.